Xin Lou
Shanghai, 200032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
DNA Repair Enzyme Regulation Strategy for Enhanced Pancreatic Neuroendocrine Tumor Therapy via Targeting siRNA-Lipid Nanoparticles.
Journal: ACS nano
Published: April 01, 2026
Tumor-derived apolipoprotein E confers resistance to temozolomide in pancreatic neuroendocrine tumors.
Journal: Cell death & disease
Published: January 10, 2025
Small extracellular vesicle-miR-183-5p mediated crosstalk between tumor cells and macrophages in high-risk pancreatic neuroendocrine tumors.
Journal: Oncogene
Published: November 06, 2024
Pancreatic Neuroendocrine Tumors Secrete Apolipoprotein E to Induce Tip Endothelial Cells That Remodel the Tumor-Stroma Ratio and Promote Cancer Progression.
Journal: Cancer research
Published: July 22, 2024
Comparison among different preclinical models derived from the same patient with a non-functional pancreatic neuroendocrine tumor.
Journal: Human cell
Published: May 12, 2024
Cancer immunometabolism: advent, challenges, and perspective.
Journal: Molecular cancer
Published: December 26, 2023
The stromal microenvironment endows pancreatic neuroendocrine tumors with spatially specific invasive and metastatic phenotypes.
Journal: Cancer letters
Published: December 20, 2023
MEN1 Deficiency-Driven Activation of the β-Catenin-MGMT Axis Promotes Pancreatic Neuroendocrine Tumor Growth and Confers Temozolomide Resistance.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 05, 2023
Recent research hotspots in sequencing and the pancreatic neuroendocrine tumor microenvironment.
Journal: Cancer biology & medicine
Published: September 29, 2023
Single-cell sequencing reveals the heterogeneity of pancreatic neuroendocrine tumors under genomic instability and histological grading.
Journal: iScience
Published: September 01, 2023
Last Updated: 09/26/2026